64
Research Trials
29
Peer-reviewed publications
17
Clinical Conditions

Updated interim data from 54 COPD patients and 135,000 monitored hours, showing cough rates rise in the days before exacerbations and correlate only weakly with CAT scores.

A month of continuous monitoring in stable chronic cough shows that multi-day averaging makes cough frequency a more reliable trial endpoint, allowing smaller studies, and reveals a short-lived Hawthorne effect.

Mixed-methods study in Kampala assessing 48-hour cough frequency monitoring with the Hyfe Research app for TB screening and triage, alongside staff-reported implementation barriers.
30 November 2025 · Journal of Thoracic Disease

Commissioned for the Thirteenth London International Cough Symposium, this narrative review by Hyfe's R&D team makes the case that continuous cough monitoring (CCM), powered by acoustic AI, transforms cough from a subjective symptom into a quantifiable digital biomarker.
The authors trace the field from the bulky tape recorders of the 1950s through today's fully passive, privacy-preserving platforms, and compare the leading commercial systems across form factor, validation, privacy architecture, and clinical adoption. They synthesize CCM findings across refractory chronic cough, COPD, bronchiectasis, heart failure, GERD, and tuberculosis, showing how continuous data has surfaced insights invisible to single-session assessment, from day-to-day variability that makes 24-hour snapshots unreliable, to cough-based early warning signals for COPD exacerbations.
The review closes with forward-looking directions including digital therapeutics, public health surveillance, regulatory pathways, and the emerging discipline of "coughomics."
Bring objective cough data to your study. Schedule a meeting →